INTECH INVESTMENT MANAGEMENT LLC

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 1086318 WEST PALM BEACH, FL

Back to BCRX Full portfolio

Position in BCRX

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$477,630

+$888 QoQ

Shares Held

47,763

-4.6% QoQ

Ownership

0.019%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#162

of 316 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Common Shares in BCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

INTECH INVESTMENT MANAGEMENT LLC holds $75,544,237 across 33 Drug Manufacturers - Specialty & Generic names. BCRX ranks #18 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd	474,709	$16,083,140
2	UTHR	UNITED THERAPEUTICS Corp	29,102	$15,768,335
3	NBIX	Neurocrine Biosciences Inc	63,662	$10,729,593
4	LNTH	Lantheus Holdings, Inc.	44,458	$4,932,170
5	INDV	Indivior Pharmaceuticals, Inc.	107,818	$4,423,772
6	ZTS	Zoetis Inc.	60,226	$4,327,839
7	ANIP	Ani Pharmaceuticals Inc	35,018	$2,898,790
8	ALKS	Alkermes plc.	40,552	$2,124,924

All Filings in BCRX

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$477,630	47,763	-4.6%	Shares	Sole	2026-08-10
2026-03-31	$476,742	50,078	-36.9%	Shares	Sole	2026-05-08
2025-12-31	$619,460	79,418	-21.6%	Shares	Sole	2026-02-10
2025-09-30	$768,381	101,236	-18.5%	Shares	Sole	2025-11-12
2025-06-30	$1,112,581	124,172	0.0%	Shares	Sole	2025-08-08
2025-03-31	$931,290	124,172	+27.0%	Shares	Sole	2025-05-20
2024-12-31	$735,403	97,793	+80.3%	Shares	Sole	2025-02-11
2024-09-30	$412,201	54,237	—	Shares	Sole	2024-11-08
No filing history on record for this holder in this stock.